Impact of tumour growth rate during preceding treatment on tumour response to regorafenib or trifluridine/tipiracil in refractory metastatic colorectal cancer

BACKGROUND: Although regorafenib (REG) and trifluridine/tipiracil (FTD/TPI) have been recognised as standard treatments in metastatic colorectal cancer (mCRC), the best option remains unclear. Pretreatment tumour growth rate (TGR) is associated with radiotherapeutic efficacy in laryngeal cancer. How...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:ESMO Open
Asıl Yazarlar: Masuishi, Toshiki, Taniguchi, Hiroya, Kawakami, Takeshi, Kawamoto, Yasuyuki, Kadowaki, Shigenori, Onozawa, Yusuke, Muranaka, Tetsuhito, Tajika, Masahiro, Yasui, Hirofumi, Nakatsumi, Hiroshi, Yuki, Satoshi, Muro, Kei, Omae, Katsuhiro, Komatsu, Yoshito, Yamazaki, Kentaro
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMJ Publishing Group 2019
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7001098/
https://ncbi.nlm.nih.gov/pubmed/32392174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2019-000584
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller